- Bosutinib v léčbě chronické myeloidní leukemie2019 | Faculty of Medicine in Hradec Králové
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. AV001Publication without faculty affiliation
- Current approach for chronic myeloid leukemia treatment with tyrosin kinase inhibitors2016 | First Faculty of Medicine
- Bosutinib versus Placebo for Autosomal Dominant Polycystic Kidney Disease2017 | First Faculty of Medicine
- Inhibition of AKR1B10-mediated metabolism of daunorubicin as a novel off-target effect for the Bcr-Abl tyrosine kinase inhibitor dasatinib2021 | Faculty of Pharmacy in Hradec Králové